178x Filetype PPTX File size 0.53 MB Source: renaissance.stonybrookmedicine.edu
Categorizing CDI – Testing and Detection Beginning January 2, 2020, Stony Brook will be utilizing a two-step testing algorithm including a PCR (polymerase chain reaction) and EIA (enzyme immunoassay) for all Inpatient and ED locations. • The PCR test is highly sensitive and specific test for toxigenic genes. It cannot distinguish between active infection and asymptomatic carriage • The EIA test has a low sensitivity, but high specificity for the toxin production. It helps to determine an active infection or asymptomatic carriage The EIA test will result after a +PCR result in PowerChart Utilizing both PCR and EIA testing helps clinicians determine an appropriate treatment plan based on active infections or asymptomatic carriage. When to Reflex? PCR + EIA Reflex Testing How to Interpret your CD Test Results PCR EIA Interpretation Treatment Recommendation Isolation Result Result Positive Positive Toxigenic C.difficile • Treat as CDI (refer to C.diff PowerPlan). • Yes detected, Suggestive • Stop acid suppression medications and of active infection concomitant antibiotics if medically safe. Negative Negative C.difficile not • No treatment for CDI recommended. • No detected • Evaluate for other causes of diarrhea. Positive Negative Suggestive of • Treatment decision should be individualized. • Yes, Colonization with • Consider treatment in those with severe, continuation C.difficile non-resolving, or otherwise unexplained to be diarrhea strongly suggestive of CDI assessed by HED Positive Pending C. Difficile detected, • Treatment decision should be individualized. • Yes active infection to be determined
no reviews yet
Please Login to review.